🇺🇸 FDA
Pipeline program

evolocumab

MR-11-23-035852

Unknown small_molecule active

Quick answer

evolocumab for STEMI is a Unknown program (small_molecule) at Beijing Luhe Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Beijing Luhe Hospital
Indication
STEMI
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials